Related Experiment Video

Updated: Jul 7, 2025

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

6.8K

cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer

Chloe Gulliver1, Tara Busiau1, Ashleigh Byrne1

  • 1School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Science, University of Glasgow, UK.

Molecular Oncology
|December 21, 2023
PubMed

Insights

Reduced levels of phosphodiesterase 4D7 (PDE4D7) protein are linked to poor prostate cancer (PCa) outcomes. This study identifies a PDE4D7-DHX9 protein complex that drives tumor growth, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Reduced phosphodiesterase 4D isoform 7 (PDE4D7) levels correlate with adverse prostate cancer (PCa) outcomes.
  • The PDE4D gene's hyper-methylation in ERG-fusion-positive PCa inhibits mRNA expression and PDE4D7 protein production.
  • The precise molecular mechanisms linking PDE4D7 reduction to PCa progression remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the relationship between PDE4D7 reduction and PCa.
  • To identify proteins interacting with PDE4D7 and understand their role in aberrant cAMP signaling in PCa.
  • To explore the potential of the PDE4D7-DHX9 complex as a therapeutic target.

Main Methods:

  • Immunopurification of PDE4D7 followed by mass spectrometry to identify binding partners.
  • Peptide array technology and proximity ligation assay to validate PDE4D7-DHX9 interaction.
  • Design and testing of a novel peptide disruptor targeting the PDE4D7-DHX9 complex.

Main Results:

  • PDE4D7 forms a novel signaling complex with ATP-dependent RNA helicase A (DHX9).
  • Disruption of the PDE4D7-DHX9 complex significantly reduced proliferation in LNCaP prostate cancer cells.
  • A new protein kinase A (PKA) phosphorylation site on DHX9, regulated by PDE4D7, was identified.

Conclusions:

  • A previously unrecognized PDE4D7-DHX9 signaling complex plays a crucial role in prostate cancer pathogenesis.
  • This complex represents a potential novel therapeutic target for prostate cancer treatment.
  • Understanding the regulation of the DHX9 phosphorylation site by PDE4D7 may offer further therapeutic insights.
Keywords:
DHX9PDE4D7disruptionphosphorylationproliferationprostate cancer

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.0K
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.1K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K